Credence Research Logo

Home » Healthcare » Pharmaceuticals » Multiple Drug Resistance (MDR) market

Multiple Drug Resistance (MDR) market

Multiple Drug Resistance (MDR) Market By Disease (Complicated Urinary Tract Infections, Clostridioides difficile Infection, Acute Bacterial Skin and Skin Structure Infections, Hospital-acquired Bacterial Pneumonia, Others); By Pathogen (E. coli, K. pneumonia, P. aeruginosa, S. aureus, Others); By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination Therapies, Others); By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 52881 | Report Format : Excel, PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Multiple Drug Resistance (MDR) Market Size 2023  USD 11,023.46 Million
Multiple Drug Resistance (MDR) Market, CAGR  5.50%
Multiple Drug Resistance (MDR) Market Size 2032  USD 17,848.02 Million

Market Overview

The Multiple Drug Resistance (MDR) market is projected to grow from USD 11,023.46 million in 2023 to an estimated USD 17,848.02 million by 2032, with a compound annual growth rate (CAGR) of 5.50% from 2024 to 2032. This growth is driven by the increasing prevalence of drug-resistant infections globally, leading to a rising demand for novel therapeutic solutions.

Key market drivers include the growing incidence of antibiotic resistance, coupled with the rising need for effective treatments in hospital settings. Additionally, government initiatives and funding for antimicrobial resistance (AMR) research are propelling market growth. Increasing awareness among healthcare providers and patients regarding the dangers of MDR is also contributing to the market’s steady expansion.

Geographically, North America dominates the MDR market due to high healthcare expenditure and strong research infrastructure. Europe follows closely, driven by government regulations and research funding. The Asia-Pacific region is expected to witness significant growth, owing to the rising incidence of drug-resistant infections. Key players in the market include Pfizer Inc., GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, and Astellas Pharma Inc., all of whom are focusing on expanding their antimicrobial portfolios.

Design Element 2

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

CTA Design Element 3

Market Drivers

Rising Prevalence of Drug-Resistant Infections

The increasing prevalence of drug-resistant infections is one of the most significant drivers of the Multiple Drug Resistance (MDR) market. Globally, the misuse and overuse of antibiotics have contributed to the rapid evolution of pathogens that are resistant to multiple drugs. The World Health Organization (WHO) has declared antimicrobial resistance (AMR) as one of the top 10 global public health threats. As bacterial, viral, and fungal pathogens evolve to resist existing treatments, healthcare systems worldwide face growing challenges in controlling infections. For instance, the CDC reported that the burden of antimicrobial-resistant pathogens increased significantly during the COVID-19 pandemic, with hospital-onset infections rising by a combined 20%. This rise in drug-resistant infections, particularly in hospital settings, has led to an increased demand for alternative and more effective therapeutic options. Infectious diseases such as tuberculosis, urinary tract infections, and pneumonia, which have historically been treatable, are becoming more difficult to manage, placing immense pressure on healthcare providers to find solutions. Consequently, the MDR market is expanding as pharmaceutical companies invest in developing new antibiotics, combination therapies, and diagnostic tools to combat these resistant pathogens.

Increasing Research and Development (R&D) Investments

Research and development play a critical role in addressing the challenges posed by multiple drug resistance. Governments, healthcare organizations, and private pharmaceutical companies are increasingly investing in R&D to develop new antimicrobial agents, vaccines, and diagnostic technologies aimed at detecting and treating drug-resistant infections. For instance, companies like GlaxoSmithKline, Pfizer, and Merck & Co. have ramped up their R&D efforts to create novel antibiotics and alternative therapies capable of targeting resistant pathogens. Additionally, public-private partnerships and global collaborations, such as the Global Antibiotic Research and Development Partnership (GARDP) and the AMR Action Fund, have been established to accelerate the development of new treatments. These initiatives are supported by significant financial investments aimed at addressing the shortage of effective drugs to treat resistant infections. The growing emphasis on innovation in drug discovery and development is a key driver of the MDR market, as the industry seeks to replenish the dwindling pipeline of effective antimicrobials.

Government Initiatives and Regulatory Support

Government policies and regulatory support are crucial in driving the growth of the MDR market. Recognizing the global threat posed by drug-resistant infections, governments and international health organizations have implemented various policies and strategies to combat antimicrobial resistance. The WHO has launched its Global Action Plan on Antimicrobial Resistance, urging countries to prioritize AMR as a public health issue. In response, many governments have developed national action plans to improve infection prevention, surveillance, and the responsible use of antibiotics. For example, the U.S. government has implemented the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), which aims to enhance prevention and control measures, promote innovation in diagnostics and treatment, and improve antibiotic stewardship. Similarly, the European Union (EU) has strengthened its regulatory framework to encourage the development of new antimicrobial drugs and ensure appropriate use. These government-led efforts are fostering a favorable environment for the growth of the MDR market, encouraging the pharmaceutical industry to focus on the development of novel therapies and improved diagnostics. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are also playing a vital role by fast-tracking approvals for new treatments addressing MDR pathogens, thereby accelerating their availability in the market.

Growing Awareness and Improved Diagnostic Technologies

Increased awareness about the dangers of antimicrobial resistance and advancements in diagnostic technologies are further driving the growth of the MDR market. Healthcare professionals and the general public are becoming more informed about the risks associated with drug-resistant infections, leading to more responsible use of antibiotics and increased demand for early detection and treatment. Awareness campaigns led by organizations such as the WHO, the Centers for Disease Control and Prevention (CDC), and other global health agencies have emphasized the importance of appropriate antibiotic use and infection control measures. As a result, there is a growing emphasis on antimicrobial stewardship programs, which aim to optimize the use of antibiotics to slow the spread of resistance. In addition to rising awareness, the development of cutting-edge diagnostic tools has significantly improved the identification of drug-resistant pathogens. Rapid diagnostic technologies, such as polymerase chain reaction (PCR) tests, next-generation sequencing (NGS), and point-of-care diagnostics, enable healthcare providers to quickly detect resistant infections and prescribe appropriate treatments. Early and accurate diagnosis is crucial in controlling the spread of MDR pathogens and improving patient outcomes. These technological advancements are facilitating more targeted therapies, reducing the reliance on broad-spectrum antibiotics, and promoting the development of personalized treatments. Consequently, the adoption of advanced diagnostics is contributing to the growth of the MDR market by enabling healthcare providers to better manage drug-resistant infections and mitigate their impact.

Market Trends

Development of Novel Antibiotics and Combination Therapies

A key trend in the Multiple Drug Resistance (MDR) market is the increasing development of novel antibiotics and combination therapies. With the growing prevalence of antimicrobial resistance, traditional antibiotics are becoming less effective, prompting the pharmaceutical industry to focus on innovative solutions. Companies are investing heavily in research and development to create next-generation antibiotics that target drug-resistant pathogens. For instance, companies like GlaxoSmithKline and Pfizer have been at the forefront of developing new antibiotics that specifically target resistant bacteria, minimizing the impact on healthy microbiota. Additionally, combination therapies, which use two or more drugs to attack different mechanisms within the pathogen, are gaining traction. These therapies reduce the likelihood of resistance development by overwhelming the bacteria’s ability to mutate against multiple drugs simultaneously. This trend is also supported by government and regulatory bodies that are fast-tracking approvals and providing incentives for antibiotic development, such as the U.S. Food and Drug Administration’s (FDA) Qualified Infectious Disease Product (QIDP) designation.

Increasing Focus on Antimicrobial Stewardship Programs

Another prominent trend in the MDR market is the growing emphasis on antimicrobial stewardship programs (ASPs). These programs are designed to optimize the use of antibiotics and reduce the unnecessary prescription of broad-spectrum antibiotics, which contributes to the rise of drug-resistant infections. Hospitals, healthcare providers, and regulatory bodies are increasingly implementing ASPs to promote responsible antibiotic use. For instance, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) are at the forefront of these efforts, offering guidelines and best practices to healthcare institutions globally. This focus on antimicrobial stewardship is leading to a more targeted approach in prescribing antibiotics, enhancing patient outcomes, and slowing the spread of resistance. Additionally, advancements in diagnostic technologies, such as rapid molecular diagnostics, are playing a crucial role in supporting ASPs by enabling quicker identification of resistant infections, thereby allowing healthcare providers to tailor treatments more effectively. These initiatives are essential in controlling the MDR crisis and are expected to significantly shape the future of the market.

Market Restraints and Challenges

High Costs and Limited Availability of Novel Treatments

One of the primary challenges in the Multiple Drug Resistance (MDR) market is the high cost associated with the development and commercialization of novel antibiotics and treatments. Research and development (R&D) in this area require significant financial investments, yet the return on investment for pharmaceutical companies can be limited. This is primarily due to the relatively short duration of antibiotic treatments compared to chronic disease therapies, which often results in lower revenue generation. For instance, the CDC reported that the direct costs for treating MDR tuberculosis patients are significantly higher compared to non-MDR TB patients. Additionally, new antibiotics are often reserved for severe cases of resistance, limiting their widespread use and profitability. Furthermore, the lengthy and complex regulatory approval processes add to the cost, slowing down the market availability of new drugs. In many regions, particularly in developing countries, the affordability and accessibility of these advanced treatments remain significant barriers. As a result, despite the urgent need for innovative solutions, the high costs and limited availability continue to restrain the market’s overall growth.

Slow Development of New Antibiotics and Emerging Resistance

Another major challenge in the MDR market is the slow pace of new antibiotic development and the continuous emergence of resistance to existing therapies. While there is increasing awareness of the antimicrobial resistance crisis, the pharmaceutical industry faces scientific and technical difficulties in discovering and developing new antibiotics. The complex nature of bacterial evolution, coupled with the rapid adaptability of pathogens, makes it difficult to stay ahead in the development of effective treatments. For instance, recent studies have highlighted the challenges in developing new antibacterial agents due to the rapid emergence of resistance. Moreover, the overuse and misuse of antibiotics in both human healthcare and agriculture accelerate the development of resistant strains, rendering many existing drugs ineffective. This dynamic creates a vicious cycle where new treatments are quickly outpaced by evolving resistance, making it harder to address the growing MDR crisis effectively. This challenge highlights the urgent need for innovative approaches in drug development and stricter antibiotic stewardship measures to combat the continuous threat of resistance.

Market Segmentation Analysis

By Disease

The MDR market is segmented by various disease categories. Complicated Urinary Tract Infections (cUTI) represent a significant portion of the market due to the high prevalence of antibiotic-resistant bacteria in urinary tract infections. Clostridioides difficile Infection (CDI) is another key segment, driven by its association with antibiotic use and the increasing difficulty in treatment. Acute bacterial skin and skin structure infections (ABSSSI) also form a notable market segment, especially in hospital settings. Hospital-acquired bacterial pneumonia (HABP) remains a major concern, with high resistance rates leading to increased demand for advanced therapeutics. Other diseases, such as bloodstream infections, further contribute to the growing demand for MDR treatments.

By Pathogen

The MDR market is classified by pathogens, with E. coli leading due to its widespread resistance in urinary and gastrointestinal infections. K. pneumoniae, commonly associated with pneumonia and bloodstream infections, is another critical pathogen driving market growth. P. aeruginosa, known for its resistance in respiratory and wound infections, significantly impacts the demand for novel antibiotics. S. aureus, particularly methicillin-resistant Staphylococcus aureus (MRSA), is a major pathogen in skin and soft tissue infections. Other pathogens contributing to the MDR market include various resistant bacterial strains affecting different regions and healthcare settings.

Segments

Based on disease

  • Complicated Urinary Tract Infections
  • Clostridioides difficile Infection
  • Acute bacterial skin and skin structure infections
  • Hospital-acquired bacterial pneumonia,Others

Based on pathogen

  • coli
  • pneumonia
  • aeruginosa
  • aureus
  • Others

Based on drug class

  • Oxazolidinones
  • Lipoglycopeptides
  • Tetracyclines
  • Combination therapies
  • Others

 Based on mechanism of action

  • Protein Synthesis Inhibitors
  • Cell Wall Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • Others

Based on distrbuion channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Regional Analysis

North America(35%):

North America holds the largest share of the MDR market, accounting for approximately 35% of the global market in 2023. The region’s dominance is driven by its advanced healthcare infrastructure, high prevalence of drug-resistant infections, and strong investment in research and development. The United States, in particular, leads in the adoption of novel antibiotics and diagnostic technologies. Government initiatives such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) also play a crucial role in driving the demand for MDR solutions. The presence of key pharmaceutical companies and high healthcare spending further contribute to North America’s leading position in the MDR market.

Europe (28%):

Europe follows closely, with around 28% of the global market share. The region’s growth is fueled by stringent regulatory policies and government-backed efforts to curb antimicrobial resistance. Countries such as the United Kingdom, Germany, and France are at the forefront of these initiatives, with robust healthcare systems and significant investments in public health campaigns aimed at promoting antibiotic stewardship. The European Union’s regulatory framework has encouraged pharmaceutical companies to focus on developing new antibiotics, further boosting the market. Additionally, rising awareness among healthcare professionals and patients about the risks of drug-resistant infections is propelling demand in this region.

Key players

  • Melinte Therapeutics
  • Basilea Pharmaceutica Ltd.
  • Tetraphase Pharmaceuticals
  • TheraVance Biopharma
  • WOCKHARDT
  • Partake Pharmaceuticals, Inc.
  • Seres Therapeutics
  • Achaogen, Inc.
  • Entasis Therapeutics
  • AbbVie
  • Merck & Co., Inc.

Competitive Analysis

The Multiple Drug Resistance (MDR) market is highly competitive, with both established pharmaceutical giants and emerging biopharma companies vying to develop innovative solutions to combat antimicrobial resistance. Key players such as Merck & Co., Inc. and AbbVie hold a strong position in the market due to their vast resources, advanced research infrastructure, and global presence. Emerging companies like Melinte Therapeutics and Partake Pharmaceuticals, Inc. are focusing on niche areas within the MDR space, developing novel antibiotics and combination therapies. Basilea Pharmaceutica Ltd. and Entasis Therapeutics are at the forefront of creating specialized treatments for drug-resistant bacterial infections. The competitive landscape is shaped by increased research and development investments, with companies aiming to bring new antibiotics and therapies to market quickly. Collaborations and partnerships are also common, as companies seek to combine their expertise to address the growing MDR crisis.

Recent Developments

  • In February 2024, Melinta Therapeutics, in collaboration with Venatorx Pharmaceuticals, announced that the U.S. FDA issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for cefepime-taniborbactam, a beta-lactam/beta-lactamase inhibitor combination antibiotic.
  • In September 2024, Basilea Pharmaceutica entered into an agreement with BARDA to develop novel antifungals and antibacterials, receiving initial funding of USD 29 million.
  • In January 2024, Theravance Biopharma announced results from the Phase 4 PIFR-2 study of YUPELRI® (revefenacin) inhalation solution, which is used for maintenance treatment of COPD.
  • In September 2023, Paratek Pharmaceuticals, Inc. was acquired by Gurnet Point Capital and Novo Holdings A/S. Their lead commercial product, NUZYRA(omadacycline), is used for treating community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
  • In September 2024, Seres Therapeutics stockholders approved the sale of the VOWST business to Nestlé Health Science. The transaction is expected to close on September 30, 2024.
  • In November 2023, Entasis Therapeutics announced positive results from a Phase 3 trial of zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea.
  • In August 2024, AbbVie completed the acquisition of Cerevel Therapeutics, which strengthens their foundation in neuroscience and complements their existing portfolio.

Market Concentration and Characteristics 

The Multiple Drug Resistance (MDR) market is moderately concentrated, with a mix of established pharmaceutical giants and emerging biotech firms competing to address the growing challenge of antimicrobial resistance. Leading companies such as Merck & Co., Inc., AbbVie, and WOCKHARDT dominate the market due to their extensive research and development capabilities, global reach, and strong product portfolios. However, emerging players like Entasis Therapeutics and Basilea Pharmaceutica Ltd. are gaining traction through innovation and niche product offerings targeting specific resistant pathogens. The market is characterized by a high level of investment in R&D, frequent strategic collaborations, and partnerships aimed at accelerating the development of novel antibiotics and therapies. Despite the growing competition, barriers to entry are relatively high due to the complex regulatory environment and the significant costs associated with drug development.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Report Coverage

The research report offers an in-depth analysis based on disease, pathogen, drug class, mechanism of action, distrbuion channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. As drug-resistant infections continue to increase, the demand for novel antibiotics and alternative therapies is expected to grow, driving innovation and market expansion.
  2. Governments and healthcare institutions will increasingly implement antimicrobial stewardship programs to promote responsible use of antibiotics, slowing the spread of drug resistance.
  3. Rapid diagnostic tools, such as molecular diagnostics and next-generation sequencing, will play a key role in early detection of MDR infections, improving treatment outcomes and reducing healthcare costs.
  4. Collaborations between pharmaceutical companies, government bodies, and academic institutions will intensify, accelerating the development of new antibiotics and treatments for MDR infections.
  5. Regulatory bodies such as the FDA and EMA are expected to offer more incentives, including fast-track approvals and extended market exclusivity, to encourage the development of new antibiotics.
  6. Emerging regions, particularly in the Asia-Pacific and Latin America, will witness significant growth due to increasing healthcare investments and rising incidence of drug-resistant infections.
  7. Combination therapies that use multiple drugs to target resistant pathogens will gain prominence, reducing the likelihood of resistance development and improving treatment efficacy.
  8. Leading pharmaceutical companies will continue to expand their antimicrobial pipelines, focusing on developing next-generation treatments targeting multidrug-resistant pathogens.
  9. The MDR market will see higher levels of R&D investment, with both public and private sectors funding innovative solutions to address the growing threat of antimicrobial resistance.
  10. Rising awareness about the dangers of antimicrobial resistance (AMR) will lead to more coordinated global efforts, with governments and international organizations prioritizing the MDR crisis.

CHAPTER NO. 1 , INTRODUCTION 35
1.1.1. Report Description 35
Purpose of the Report 35
USP & Key Offerings 35
1.1.2. Key Benefits for Stakeholders 35
1.1.3. Target Audience 36
1.1.4. Report Scope 36
1.1.5. Regional Scope 37
CHAPTER NO. 2 , EXECUTIVE SUMMARY 38
2.1. Multiple Drug Resistance Bacterial Infection Treatment Market Snapshot 38
2.1.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market, 2018 – 2032 (Units) (USD Million) 41
2.2. Insights from Primary Respondents 41
CHAPTER NO. 3 , GEOPOLITICAL CRISIS IMPACT ANALYSIS 42
3.1. Russia-Ukraine and Israel-Palestine War Impacts 42
CHAPTER NO. 4 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – INDUSTRY ANALYSIS 43
4.1. Introduction 43
4.2. Market Drivers 44
4.2.1. Driving Factor 1 Analysis 44
4.2.2. Driving Factor 2 Analysis 45
4.3. Market Restraints 46
4.3.1. Restraining Factor Analysis 46
4.4. Market Opportunities 47
4.4.1. Market Opportunity Analysis 47
4.5. Porter’s Five Forces Analysis 48
CHAPTER NO. 5 , ANALYSIS COMPETITIVE LANDSCAPE 49
5.1. Company Market Share Analysis – 2023 49
5.1.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market, Company Market Share, Based on Volume, 2023 49
5.1.2. Global Multiple Drug Resistance Bacterial Infection Treatment Market, Company Market Share, Based on Revenue, 2023 50
5.1.3. Global Multiple Drug Resistance Bacterial Infection Treatment Market, Top 6 Company Market Share, Based on Revenue, 2023 50
5.1.4. Global Multiple Drug Resistance Bacterial Infection Treatment Market, Top 3 Company Market Share, Based on Revenue, 2023 51
5.2. Global Multiple Drug Resistance Bacterial Infection Treatment Market Company Volume Market Share, 2023 52
5.3. Company Assessment Metrics, 2023 53
5.3.1. Stars 53
5.3.2. Emerging Leaders 53
5.3.3. Pervasive Players 53
5.3.4. Participants 53
5.4. Start-ups /SMEs Assessment Metrics, 2023 53
5.4.1. Progressive Companies 53
5.4.2. Responsive Companies 53
5.4.3. Dynamic Companies 53
5.4.4. Starting Blocks 53
5.5. Strategic Developments 54
5.5.1. Acquisitions & Mergers 54
New Product Launch 54
Regional Expansion 54
5.6. Key Players Product Matrix 56
CHAPTER NO. 6 , PESTEL & ADJACENT MARKET ANALYSIS 57
6.1. PESTEL 57
6.1.1. Political Factors 57
6.1.2. Economic Factors 57
6.1.3. Social Factors 57
6.1.4. Technological Factors 57
6.1.5. Environmental Factors 57
6.1.6. Legal Factors 57
6.2. Adjacent Market Analysis 57
CHAPTER NO. 7 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – BASED ON DISEASE SEGMENT ANALYSIS 58
7.1. Multiple Drug Resistance Bacterial Infection Treatment Market Overview, Based on Disease Segment 58
7.1.1. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Disease, 2023 & 2032 59
7.1.2. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Disease, 2023 & 2032 59
7.1.3. Multiple Drug Resistance Bacterial Infection Treatment Market Attractiveness Analysis, Based on Disease 60
7.1.4. Incremental Revenue Growth Opportunity, Based on Disease, 2024 – 2032 60
7.1.5. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018, 2023, 2027 & 2032 61
7.2. Complicated Urinary Tract Infections 62
7.2.1. Global Complicated Urinary Tract Infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 63
7.2.2. Global Complicated Urinary Tract Infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 64
7.3. Clostridioides difficile Infection 65
7.3.1. Global Clostridioides difficile Infection Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 66
7.3.2. Global Clostridioides difficile Infection Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 67
7.4. Acute bacterial skin and skin structure infections 68
7.5. Global Acute bacterial skin and skin structure infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 69
7.6. Global Acute bacterial skin and skin structure infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 70
7.7. Hospital-acquired bacterial pneumonia 71
7.7.1. Global Hospital-acquired bacterial pneumonia Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 72
7.7.2. Global Hospital-acquired bacterial pneumonia Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 73
7.8. Others 74
7.8.1. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 75
7.8.2. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 75
CHAPTER NO. 8 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – BASED ON PATHOGEN SEGMENT ANALYSIS 76
8.1. Multiple Drug Resistance Bacterial Infection Treatment Market Overview, Based on Pathogen Segment 76
8.1.1. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Pathogen, 2023 & 2032 77
8.1.2. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Pathogen, 2023 & 2032 77
8.1.3. Multiple Drug Resistance Bacterial Infection Treatment Market Attractiveness Analysis, Based on Pathogen 78
8.1.4. Incremental Revenue Growth Opportunity, Based on Pathogen, 2024 – 2032 78
8.1.5. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018, 2023, 2027 & 2032 79
8.2. E. coli 80
8.2.1. Global E. coli Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 81
8.2.2. Global E. coli Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 81
8.3. K. pneumoniae 82
8.3.1. Global K. pneumoniae Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 83
8.3.2. Global K. pneumoniae Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 83
8.4. P. aeruginosa 84
8.5. Global P. aeruginosa Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 85
8.6. Global P. aeruginosa Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 85
8.7. S. aureus 86
8.7.1. Global S. aureus Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 87
8.7.2. Global S. aureus Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 87
8.8. Others 88
8.8.1. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 89
8.8.2. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 89
CHAPTER NO. 9 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – BASED ON DRUG CLASS SEGMENT ANALYSIS 90
9.1. Multiple Drug Resistance Bacterial Infection Treatment Market Overview, Based on Drug Class Segment 90
9.1.1. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Drug Class, 2023 & 2032 91
9.1.2. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Drug Class, 2023 & 2032 91
9.1.3. Multiple Drug Resistance Bacterial Infection Treatment Market Attractiveness Analysis, Based on Drug Class 92
9.1.4. Incremental Revenue Growth Opportunity, Based on Drug Class, 2024 – 2032 92
9.1.5. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018, 2023, 2027 & 2032 93
9.2. Oxazolidinones 94
9.2.1. Global Oxazolidinones Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 95
9.2.2. Global Oxazolidinones Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 95
9.3. Lipoglycopeptides 96
9.3.1. Global Lipoglycopeptides Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 97
9.3.2. Global Lipoglycopeptides Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 97
9.4. Tetracyclines 98
9.5. Global Tetracyclines Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 99
9.6. Global Tetracyclines Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 99
9.7. Combination therapies 100
9.7.1. Global Combination therapies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 101
9.7.2. Global Combination therapies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 101
9.8. Others 102
9.8.1. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 103
9.8.2. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 103
CHAPTER NO. 10 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – BASED ON MECHANISM OF ACTION SEGMENT ANALYSIS 104
10.1. Multiple Drug Resistance Bacterial Infection Treatment Market Overview, Based on Mechanism of Action Segment 104
10.1.1. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Mechanism of Action, 2023 & 2032 105
10.1.2. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Mechanism of Action, 2023 & 2032 105
10.1.3. Multiple Drug Resistance Bacterial Infection Treatment Market Attractiveness Analysis, Based on Mechanism of Action 106
10.1.4. Incremental Revenue Growth Opportunity, Based on Mechanism of Action, 2024 – 2032 106
10.1.5. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018, 2023, 2027 & 2032 107
10.2. Protein Synthesis Inhibitors 108
10.2.1. Global Protein Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 109
10.2.2. Global Protein Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 109
10.3. Cell Wall Synthesis Inhibitors 110
10.3.1. Global Cell Wall Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 111
10.3.2. Global Cell Wall Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 111
10.4. RNA Synthesis Inhibitors 112
10.5. Global RNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 113
10.6. Global RNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 113
10.7. DNA Synthesis Inhibitors 114
10.7.1. Global DNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 115
10.7.2. Global DNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 115
10.8. Others 116
10.8.1. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 117
10.8.2. Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 117
CHAPTER NO. 11 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – BASED ON DISTRIBUTION CHANNEL SEGMENT ANALYSIS 118
11.1. Multiple Drug Resistance Bacterial Infection Treatment Market Overview, Based on Distribution Channel Segment 118
11.1.1. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Distribution Channel, 2023 & 2032 119
11.1.2. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Distribution Channel, 2023 & 2032 119
11.1.3. Multiple Drug Resistance Bacterial Infection Treatment Market Attractiveness Analysis, Based on Distribution Channel 120
11.1.4. Incremental Revenue Growth Opportunity, Based on Distribution Channel, 2024 – 2032 120
11.1.5. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018, 2023, 2027 & 2032 121
11.2. Hospital Pharmacies 122
11.2.1. Global Hospital Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 123
11.2.2. Global Hospital Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 124
11.3. Retail Pharmacies 125
11.3.1. Global Retail Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 126
11.3.2. Global Retail Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 127
11.4. Online Pharmacies 128
11.5. Global Online Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 129
11.6. Global Online Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 130
CHAPTER NO. 12 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – REGIONAL ANALYSIS 131
12.1. Multiple Drug Resistance Bacterial Infection Treatment Market Overview, Based on Regional Segments 131
12.2. Region 132
12.2.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Region, 2023 & 2032 132
12.2.2. Global Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Region, 2023 & 2032 132
12.2.3. Multiple Drug Resistance Bacterial Infection Treatment Market Attractiveness Analysis, Based on Region 133
12.2.4. Incremental Revenue Growth Opportunity, Based on Region, 2024 – 2032 133
12.2.5. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Region, 2018, 2023, 2027 & 2032 134
12.2.6. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 135
12.2.7. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 135
12.3. Disease 136
12.3.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Disease, 2018 – 2023 (Units) (USD Million) 136
12.4. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Disease, 2024 – 2032 (Units) (USD Million) 137
12.5. Pathogen 138
12.5.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Pathogen, 2018 – 2023 (Units) (USD Million) 138
12.5.2. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Pathogen, 2024 – 2032 (Units) (USD Million) 139
12.6. Drug Class 140
12.6.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Drug Class, 2018 – 2023 (Units) (USD Million) 140
12.6.2. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Drug Class, 2024 – 2032 (Units) (USD Million) 141
12.7. Mechanism of Action 142
12.7.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Mechanism of Action, 2018 – 2023 (Units) (USD Million) 142
12.7.2. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Mechanism of Action, 2024 – 2032 (Units) (USD Million) 143
12.8. Distribution Channel 144
12.8.1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Distribution Channel, 2018 – 2023 (Units) (USD Million) 144
12.8.2. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Distribution Channel, 2024 – 2032 (Units) (USD Million) 145
CHAPTER NO. 13 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – NORTH AMERICA 146
13.1. North America 146
13.1.1. Key Highlights 146
13.1.2. North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2032 (Units) 147
13.1.3. North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 148
13.1.4. North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 149
13.1.5. North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 150
13.1.6. North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 151
13.1.7. North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 152
13.1.8. North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 153
13.1.9. North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 154
13.1.10. North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 155
13.1.11. North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 156
13.1.12. North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 157
13.1.13. North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 158
13.2. U.S. 159
13.3. Canada 159
13.4. Mexico 159
CHAPTER NO. 14 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – EUROPE 160
14.1. Europe 160
14.1.1. Key Highlights 160
14.1.2. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2032 (Units) 161
14.1.3. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 162
14.1.4. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 163
14.1.5. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 164
14.1.6. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 165
14.1.7. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 166
14.1.8. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 167
14.1.9. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 168
14.1.10. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 169
14.1.11. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 170
14.1.12. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 171
14.1.13. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 172
14.2. UK 173
14.3. France 173
14.4. Germany 173
14.5. Italy 173
14.6. Spain 173
14.7. Russia 173
14.8. Belgium 173
14.9. Netherland 173
14.10. Austria 173
14.11. Sweden 173
14.12. Poland 173
14.13. Denmark 173
14.14. Switzerland 173
14.15. Rest of Europe 173
CHAPTER NO. 15 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – ASIA PACIFIC 174
15.1. Asia Pacific 174
15.1.1. Key Highlights 174
15.1.2. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2032 (Units) 175
15.1.3. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 176
15.1.4. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 177
15.1.5. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 178
15.1.6. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 179
15.1.7. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 180
15.1.8. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 181
15.1.9. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 182
15.1.10. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 183
15.1.11. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 184
15.1.12. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 185
15.1.13. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 186
15.2. China 187
15.3. Japan 187
15.4. South Korea 187
15.5. India 187
15.6. Australia 187
15.7. Thailand 187
15.8. Indonesia 187
15.9. Vietnam 187
15.10. Malaysia 187
15.11. Philippines 187
15.12. Taiwan 187
15.13. Rest of Asia Pacific 187
CHAPTER NO. 16 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – LATIN AMERICA 188
16.1. Latin America 188
16.1.1. Key Highlights 188
16.1.2. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2032 (Units) 189
16.1.3. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 190
16.1.4. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 191
16.1.5. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 192
16.1.6. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 193
16.1.7. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 194
16.1.8. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 195
16.1.9. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 196
16.1.10. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 197
16.1.11. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 198
16.1.12. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 199
16.1.13. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 200
16.2. Brazil 201
16.3. Argentina 201
16.4. Peru 201
16.5. Chile 201
16.6. Colombia 201
16.7. Rest of Latin America 201
CHAPTER NO. 17 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – MIDDLE EAST 202
17.1. Middle East 202
17.1.1. Key Highlights 202
17.1.2. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2032 (Units) 203
17.1.3. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 204
17.1.4. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 205
17.1.5. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 206
17.1.6. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 207
17.1.7. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 208
17.1.8. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 209
17.1.9. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 210
17.1.10. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 211
17.1.11. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 212
17.1.12. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 213
17.1.13. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 214
17.2. UAE 215
17.3. KSA 215
17.4. Israel 215
17.5. Turkey 215
17.6. Iran 215
17.7. Rest of Middle East 215
CHAPTER NO. 18 , MULTIPLE DRUG RESISTANCE BACTERIAL INFECTION TREATMENT MARKET – AFRICA 216
18.1. Africa 216
18.1.1. Key Highlights 216
18.1.2. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2032 (Units) 217
18.1.3. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 218
18.1.4. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 219
18.1.5. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 221
18.1.6. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 222
18.1.7. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 223
18.1.8. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 224
18.1.9. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 225
18.1.10. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 226
18.1.11. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 227
18.1.12. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 228
18.1.13. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 229
18.2. Egypt 230
18.3. Nigeria 230
18.4. Algeria 230
18.5. Morocco 230
18.6. Rest of Africa 230
CHAPTER NO. 19 , COMPANY PROFILES 231
19.1. Melinte Therapeutics 231
19.1.1. Company Overview 231
19.1.2. Product Portfolio 231
19.1.3. Swot Analysis 231
19.1.4. Business Strategy 231
19.1.5. Financial Overview 232
19.2. Basilea Pharmaceutica Ltd. 233
19.3. Tetra phase Pharmaceuticals 233
19.4. Thera Vance Biopharma 233
19.5. WOCKHARDT 233
19.6. Partake Pharmaceuticals, Inc. 233
19.7. Seres Therapeutics 233
19.8. ACHAOGEN, INC. 233
19.9. Entasis therapeutics 233
19.10. AbbVie 233
19.11. Merck & Co. Inc 233
CHAPTER NO. 20 , RESEARCH METHODOLOGY 234
20.1. Research Methodology 234
20.1.1. Phase I – Secondary Research 235
20.1.2. Phase II – Data Modeling 235
Company Share Analysis Model 236
Revenue Based Modeling 236
20.1.3. Phase III – Primary Research 237
20.1.4. Research Limitations 238
Assumptions 238
 
List of Figures
FIG NO. 1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, 2018 – 2032 (Units) (USD Million) 40
FIG NO. 2. Porter’s Five Forces Analysis for Global Multiple Drug Resistance Bacterial Infection Treatment Market 47
FIG NO. 3. Company Share Analysis, 2023 48
FIG NO. 4. Company Share Analysis, 2023 49
FIG NO. 5. Company Share Analysis, 2023 49
FIG NO. 6. Company Share Analysis, 2023 50
FIG NO. 7. Multiple Drug Resistance Bacterial Infection Treatment Market – Company Volume Market Share, 2023 51
FIG NO. 8. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Disease, 2023 & 2032 58
FIG NO. 9. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Disease, 2023 & 2032 58
FIG NO. 10. Market Attractiveness Analysis, Based on Disease 59
FIG NO. 11. Incremental Revenue Growth Opportunity Based on Disease, 2024 – 2032 59
FIG NO. 12. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018, 2023, 2027 & 2032 60
FIG NO. 13. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Complicated Urinary Tract Infections, Volume & Revenue (Units) (USD Million) 2018 – 2032 61
FIG NO. 14. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Clostridioides difficile Infection, Volume & Revenue (Units) (USD Million) 2018 – 2032 64
FIG NO. 15. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Acute bacterial skin and skin structure infections, Volume & Revenue (Units) (USD Million) 2018 – 2032 67
FIG NO. 16. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Hospital-acquired bacterial pneumonia, Volume & Revenue (Units) (USD Million) 2018 – 2032 70
FIG NO. 17. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Others, Volume & Revenue (Units) (USD Million) 2018 – 2032 73
FIG NO. 18. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Pathogen, 2023 & 2032 76
FIG NO. 19. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Pathogen, 2023 & 2032 76
FIG NO. 20. Market Attractiveness Analysis, Based on Pathogen 77
FIG NO. 21. Incremental Revenue Growth Opportunity Based on Pathogen, 2024 – 2032 77
FIG NO. 22. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018, 2023, 2027 & 2032 78
FIG NO. 23. Global Multiple Drug Resistance Bacterial Infection Treatment Market for E. coli, Volume & Revenue (Units) (USD Million) 2018 – 2032 79
FIG NO. 24. Global Multiple Drug Resistance Bacterial Infection Treatment Market for K. pneumoniae, Volume & Revenue (Units) (USD Million) 2018 – 2032 81
FIG NO. 25. Global Multiple Drug Resistance Bacterial Infection Treatment Market for P. aeruginosa, Volume & Revenue (Units) (USD Million) 2018 – 2032 83
FIG NO. 26. Global Multiple Drug Resistance Bacterial Infection Treatment Market for S. aureus, Volume & Revenue (Units) (USD Million) 2018 – 2032 85
FIG NO. 27. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Others, Volume & Revenue (Units) (USD Million) 2018 – 2032 87
FIG NO. 28. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Drug Class, 2023 & 2032 90
FIG NO. 29. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Drug Class, 2023 & 2032 90
FIG NO. 30. Market Attractiveness Analysis, Based on Drug Class 91
FIG NO. 31. Incremental Revenue Growth Opportunity Based on Drug Class, 2024 – 2032 91
FIG NO. 32. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018, 2023, 2027 & 2032 92
FIG NO. 33. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Oxazolidinones, Volume & Revenue (Units) (USD Million) 2018 – 2032 93
FIG NO. 34. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Lipoglycopeptides, Volume & Revenue (Units) (USD Million) 2018 – 2032 95
FIG NO. 35. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Tetracyclines, Volume & Revenue (Units) (USD Million) 2018 – 2032 97
FIG NO. 36. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Combination therapies, Volume & Revenue (Units) (USD Million) 2018 – 2032 99
FIG NO. 37. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Others, Volume & Revenue (Units) (USD Million) 2018 – 2032 101
FIG NO. 38. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Mechanism of Action, 2023 & 2032 104
FIG NO. 39. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Mechanism of Action, 2023 & 2032 104
FIG NO. 40. Market Attractiveness Analysis, Based on Mechanism of Action 105
FIG NO. 41. Incremental Revenue Growth Opportunity Based on Mechanism of Action, 2024 – 2032 105
FIG NO. 42. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018, 2023, 2027 & 2032 106
FIG NO. 43. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Protein Synthesis Inhibitors, Volume & Revenue (Units) (USD Million) 2018 – 2032 107
FIG NO. 44. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Cell Wall Synthesis Inhibitors, Volume & Revenue (Units) (USD Million) 2018 – 2032 109
FIG NO. 45. Global Multiple Drug Resistance Bacterial Infection Treatment Market for RNA Synthesis Inhibitors, Volume & Revenue (Units) (USD Million) 2018 – 2032 111
FIG NO. 46. Global Multiple Drug Resistance Bacterial Infection Treatment Market for DNA Synthesis Inhibitors, Volume & Revenue (Units) (USD Million) 2018 – 2032 113
FIG NO. 47. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Others, Volume & Revenue (Units) (USD Million) 2018 – 2032 115
FIG NO. 48. Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Distribution Channel, 2023 & 2032 118
FIG NO. 49. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Distribution Channel, 2023 & 2032 118
FIG NO. 50. Market Attractiveness Analysis, Based on Distribution Channel 119
FIG NO. 51. Incremental Revenue Growth Opportunity Based on Distribution Channel, 2024 – 2032 119
FIG NO. 52. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018, 2023, 2027 & 2032 120
FIG NO. 53. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Hospital Pharmacies, Volume & Revenue (Units) (USD Million) 2018 – 2032 121
FIG NO. 54. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Retail Pharmacies, Volume & Revenue (Units) (USD Million) 2018 – 2032 124
FIG NO. 55. Global Multiple Drug Resistance Bacterial Infection Treatment Market for Online Pharmacies, Volume & Revenue (Units) (USD Million) 2018 – 2032 127
FIG NO. 56. Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume Share, Based on Region, 2023 & 2032 131
FIG NO. 57. Global Multiple Drug Resistance Bacterial Infection Treatment Market Revenue Share, Based on Region, 2023 & 2032 131
FIG NO. 58. Market Attractiveness Analysis, Based on Region 132
FIG NO. 59. Incremental Revenue Growth Opportunity Based on Region, 2024 – 2032 132
FIG NO. 60. Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Region, 2018, 2023, 2027 & 2032 133
FIG NO. 61. North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, 2018 – 2032 (Units) (USD Million) 145
FIG NO. 62. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, 2018 – 2032 (Units) (USD Million) 159
FIG NO. 63. Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, 2018 – 2032 (Units) (USD Million) 173
FIG NO. 64. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, 2018 – 2032 (Units) (USD Million) 187
FIG NO. 65. Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, 2018 – 2032 (Units) (USD Million) 201
FIG NO. 66. Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, 2018 – 2032 (Units) (USD Million) 215
FIG NO. 67. Research Methodology – Detailed View 233
FIG NO. 68. Research Methodology 234

List of Tables
TABLE NO. 1. , Global Multiple Drug Resistance Bacterial Infection Treatment Market, Snapshot 37
TABLE NO. 2. , Drivers for the Multiple Drug Resistance Bacterial Infection Treatment Market, Impact Analysis 43
TABLE NO. 3. , Restraints for the Multiple Drug Resistance Bacterial Infection Treatment Market, Impact Analysis 45
TABLE NO. 4. , Global Complicated Urinary Tract Infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 62
TABLE NO. 5. , Global Complicated Urinary Tract Infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 63
TABLE NO. 6. , Global Clostridioides difficile Infection Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 65
TABLE NO. 7. , Global Clostridioides difficile Infection Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 66
TABLE NO. 8. , Global Acute bacterial skin and skin structure infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 68
TABLE NO. 9. , Global Acute bacterial skin and skin structure infections Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 69
TABLE NO. 10. , Global Hospital-acquired bacterial pneumonia Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 71
TABLE NO. 11. , Global Hospital-acquired bacterial pneumonia Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 72
TABLE NO. 12. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 74
TABLE NO. 13. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 74
TABLE NO. 14. , Global E. coli Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 80
TABLE NO. 15. , Global E. coli Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 80
TABLE NO. 16. , Global K. pneumoniae Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 82
TABLE NO. 17. , Global K. pneumoniae Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 82
TABLE NO. 18. , Global P. aeruginosa Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 84
TABLE NO. 19. , Global P. aeruginosa Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 84
TABLE NO. 20. , Global S. aureus Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 86
TABLE NO. 21. , Global S. aureus Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 86
TABLE NO. 22. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 88
TABLE NO. 23. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 88
TABLE NO. 24. , Global Oxazolidinones Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 94
TABLE NO. 25. , Global Oxazolidinones Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 94
TABLE NO. 26. , Global Lipoglycopeptides Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 96
TABLE NO. 27. , Global Lipoglycopeptides Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 96
TABLE NO. 28. , Global Tetracyclines Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 98
TABLE NO. 29. , Global Tetracyclines Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 98
TABLE NO. 30. , Global Combination therapies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 100
TABLE NO. 31. , Global Combination therapies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 100
TABLE NO. 32. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 102
TABLE NO. 33. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 102
TABLE NO. 34. , Global Protein Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 108
TABLE NO. 35. , Global Protein Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 108
TABLE NO. 36. , Global Cell Wall Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 110
TABLE NO. 37. , Global Cell Wall Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 110
TABLE NO. 38. , Global RNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 112
TABLE NO. 39. , Global RNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 112
TABLE NO. 40. , Global DNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 114
TABLE NO. 41. , Global DNA Synthesis Inhibitors Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 114
TABLE NO. 42. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 116
TABLE NO. 43. , Global Others Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 116
TABLE NO. 44. , Global Hospital Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 122
TABLE NO. 45. , Global Hospital Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 123
TABLE NO. 46. , Global Retail Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 125
TABLE NO. 47. , Global Retail Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 126
TABLE NO. 48. , Global Online Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 128
TABLE NO. 49. , Global Online Pharmacies Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 129
TABLE NO. 50. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2018 – 2023 (Units) (USD Million) 134
TABLE NO. 51. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Region, 2024 – 2032 (Units) (USD Million) 134
TABLE NO. 52. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Disease, 2018 – 2023 (Units) (USD Million) 135
TABLE NO. 53. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Disease, 2024 – 2032 (Units) (USD Million) 136
TABLE NO. 54. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Pathogen, 2018 – 2023 (Units) (USD Million) 137
TABLE NO. 55. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Pathogen, 2024 – 2032 (Units) (USD Million) 138
TABLE NO. 56. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Drug Class, 2018 – 2023 (Units) (USD Million) 139
TABLE NO. 57. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Drug Class, 2024 – 2032 (Units) (USD Million) 140
TABLE NO. 58. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Mechanism of Action, 2018 – 2023 (Units) (USD Million) 141
TABLE NO. 59. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Mechanism of Action, 2024 – 2032 (Units) (USD Million) 142
TABLE NO. 60. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Distribution Channel, 2018 – 2023 (Units) (USD Million) 143
TABLE NO. 61. , Global Multiple Drug Resistance Bacterial Infection Treatment Market Volume & Revenue, Based on Distribution Channel, 2024 – 2032 (Units) (USD Million) 144
TABLE NO. 62. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2023 (Units) 146
TABLE NO. 63. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2024 – 2032 (Units) 146
TABLE NO. 64. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 147
TABLE NO. 65. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2024 – 2032 (USD Million) 147
TABLE NO. 66. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 148
TABLE NO. 67. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2024 – 2032 (Units) 148
TABLE NO. 68. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 149
TABLE NO. 69. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2024 – 2032 (USD Million) 149
TABLE NO. 70. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 150
TABLE NO. 71. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2024 – 2032 (Units) 150
TABLE NO. 72. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 151
TABLE NO. 73. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2024 – 2032 (USD Million) 151
TABLE NO. 74. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 152
TABLE NO. 75. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2024 – 2032 (Units) 152
TABLE NO. 76. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 153
TABLE NO. 77. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2024 – 2032 (USD Million) 153
TABLE NO. 78. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 154
TABLE NO. 79. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2024 – 2032 (Units) 154
TABLE NO. 80. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 155
TABLE NO. 81. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2024 – 2032 (USD Million) 155
TABLE NO. 82. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 156
TABLE NO. 83. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2024 – 2032 (Units) 156
TABLE NO. 84. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 157
TABLE NO. 85. , North America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2024 – 2032 (USD Million) 157
TABLE NO. 86. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2023 (Units) 160
TABLE NO. 87. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2024 – 2032 (Units) 160
TABLE NO. 88. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 161
TABLE NO. 89. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2024 – 2032 (USD Million) 161
TABLE NO. 90. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 162
TABLE NO. 91. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2024 – 2032 (Units) 162
TABLE NO. 92. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 163
TABLE NO. 93. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2024 – 2032 (USD Million) 163
TABLE NO. 94. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 164
TABLE NO. 95. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2024 – 2032 (Units) 164
TABLE NO. 96. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 165
TABLE NO. 97. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2024 – 2032 (USD Million) 165
TABLE NO. 98. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 166
TABLE NO. 99. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2024 – 2032 (Units) 166
TABLE NO. 100. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 167
TABLE NO. 101. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2024 – 2032 (USD Million) 167
TABLE NO. 102. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 168
TABLE NO. 103. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2024 – 2032 (Units) 168
TABLE NO. 104. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 169
TABLE NO. 105. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2024 – 2032 (USD Million) 169
TABLE NO. 106. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 170
TABLE NO. 107. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2024 – 2032 (Units) 170
TABLE NO. 108. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 171
TABLE NO. 109. , Europe Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2024 – 2032 (USD Million) 171
TABLE NO. 110. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2023 (Units) 174
TABLE NO. 111. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2024 – 2032 (Units) 174
TABLE NO. 112. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 175
TABLE NO. 113. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2024 – 2032 (USD Million) 175
TABLE NO. 114. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 176
TABLE NO. 115. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2024 – 2032 (Units) 176
TABLE NO. 116. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 177
TABLE NO. 117. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2024 – 2032 (USD Million) 177
TABLE NO. 118. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 178
TABLE NO. 119. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2024 – 2032 (Units) 178
TABLE NO. 120. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 179
TABLE NO. 121. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2024 – 2032 (USD Million) 179
TABLE NO. 122. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 180
TABLE NO. 123. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2024 – 2032 (Units) 180
TABLE NO. 124. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 181
TABLE NO. 125. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2024 – 2032 (USD Million) 181
TABLE NO. 126. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 182
TABLE NO. 127. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2024 – 2032 (Units) 182
TABLE NO. 128. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 183
TABLE NO. 129. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2024 – 2032 (USD Million) 183
TABLE NO. 130. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 184
TABLE NO. 131. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2024 – 2032 (Units) 184
TABLE NO. 132. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 185
TABLE NO. 133. , Asia Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2024 – 2032 (USD Million) 185
TABLE NO. 134. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2023 (Units) 188
TABLE NO. 135. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2024 – 2032 (Units) 188
TABLE NO. 136. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 189
TABLE NO. 137. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2024 – 2032 (USD Million) 189
TABLE NO. 138. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 190
TABLE NO. 139. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2024 – 2032 (Units) 190
TABLE NO. 140. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 191
TABLE NO. 141. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2024 – 2032 (USD Million) 191
TABLE NO. 142. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 192
TABLE NO. 143. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2024 – 2032 (Units) 192
TABLE NO. 144. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 193
TABLE NO. 145. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2024 – 2032 (USD Million) 193
TABLE NO. 146. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 194
TABLE NO. 147. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2024 – 2032 (Units) 194
TABLE NO. 148. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 195
TABLE NO. 149. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2024 – 2032 (USD Million) 195
TABLE NO. 150. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 196
TABLE NO. 151. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2024 – 2032 (Units) 196
TABLE NO. 152. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 197
TABLE NO. 153. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2024 – 2032 (USD Million) 197
TABLE NO. 154. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 198
TABLE NO. 155. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2024 – 2032 (Units) 198
TABLE NO. 156. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 199
TABLE NO. 157. , Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2024 – 2032 (USD Million) 199
TABLE NO. 158. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2023 (Units) 202
TABLE NO. 159. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2024 – 2032 (Units) 202
TABLE NO. 160. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 203
TABLE NO. 161. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2024 – 2032 (USD Million) 203
TABLE NO. 162. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 204
TABLE NO. 163. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2024 – 2032 (Units) 204
TABLE NO. 164. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 205
TABLE NO. 165. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2024 – 2032 (USD Million) 205
TABLE NO. 166. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 206
TABLE NO. 167. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2024 – 2032 (Units) 206
TABLE NO. 168. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 207
TABLE NO. 169. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2024 – 2032 (USD Million) 207
TABLE NO. 170. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 208
TABLE NO. 171. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2024 – 2032 (Units) 208
TABLE NO. 172. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 209
TABLE NO. 173. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2024 – 2032 (USD Million) 209
TABLE NO. 174. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 210
TABLE NO. 175. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2024 – 2032 (Units) 210
TABLE NO. 176. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 211
TABLE NO. 177. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2024 – 2032 (USD Million) 211
TABLE NO. 178. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 212
TABLE NO. 179. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2024 – 2032 (Units) 212
TABLE NO. 180. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 213
TABLE NO. 181. , Middle East Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2024 – 2032 (USD Million) 213
TABLE NO. 182. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2018 – 2023 (Units) 216
TABLE NO. 183. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Country, 2024 – 2032 (Units) 216
TABLE NO. 184. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2018 – 2023 (USD Million) 217
TABLE NO. 185. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Country, 2024 – 2032 (USD Million) 217
TABLE NO. 186. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2018 – 2023 (Units) 218
TABLE NO. 187. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Disease, 2024 – 2032 (Units) 218
TABLE NO. 188. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2018 – 2023 (USD Million) 220
TABLE NO. 189. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Disease, 2024 – 2032 (USD Million) 220
TABLE NO. 190. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2018 – 2023 (Units) 221
TABLE NO. 191. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Pathogen, 2024 – 2032 (Units) 221
TABLE NO. 192. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2018 – 2023 (USD Million) 222
TABLE NO. 193. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Pathogen, 2024 – 2032 (USD Million) 222
TABLE NO. 194. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2018 – 2023 (Units) 223
TABLE NO. 195. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Drug Class, 2024 – 2032 (Units) 223
TABLE NO. 196. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2018 – 2023 (USD Million) 224
TABLE NO. 197. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Drug Class, 2024 – 2032 (USD Million) 224
TABLE NO. 198. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2018 – 2023 (Units) 225
TABLE NO. 199. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Mechanism of Action, 2024 – 2032 (Units) 225
TABLE NO. 200. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2018 – 2023 (USD Million) 226
TABLE NO. 201. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Mechanism of Action, 2024 – 2032 (USD Million) 226
TABLE NO. 202. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2018 – 2023 (Units) 227
TABLE NO. 203. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Volume, Based on Distribution Channel, 2024 – 2032 (Units) 227
TABLE NO. 204. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2018 – 2023 (USD Million) 228
TABLE NO. 205. , Africa Multiple Drug Resistance Bacterial Infection Treatment Market Revenue, Based on Distribution Channel, 2024 – 2032 (USD Million) 228

Frequently Asked Questions:

What is the market size of the Multiple Drug Resistance (MDR) market in 2023 and 2032?

The MDR market is projected to grow from USD 11,023.46 million in 2023 to an estimated USD 17,848.02 million by 2032, with a CAGR of 5.50% from 2024 to 2032.

What are the key factors driving the growth of the MDR market?

The rising prevalence of drug-resistant infections, increased investments in research and development, and government initiatives supporting antimicrobial resistance (AMR) research are key growth drivers.

Which regions hold the largest share in the MDR market?

North America dominates the MDR market with a 35% market share, followed by Europe with 28%. The Asia-Pacific region is expected to witness significant growth in the coming years.

How are pharmaceutical companies addressing the issue of drug resistance?

Pharmaceutical companies are investing heavily in developing novel antibiotics, combination therapies, and diagnostic tools to combat drug-resistant pathogens effectively.

What role do government initiatives play in the MDR market?

Governments worldwide are implementing national action plans, providing regulatory support, and fast-tracking approvals for novel antibiotics to address the growing threat of antimicrobial resistance.

Related Reports By Keyword

Reconfigurable Optical Add and Drop Multiplexing Market

Published:
Report ID: 87027

Multiple Unit Pellet Systems Market

Published:
Report ID: 71329

Wavelength Division Multiplexing Equipment Market

Published:
Report ID: 68951

Wavelength Division Multiplexers (WDM) Market

Published:
Report ID: 11653

Multiple Sclerosis Therapeutics Market

Published:
Report ID: 56966

Multiplexed Diagnostics Market

Published:
Report ID: 14279

Multiple Input Multiple Output (MIMO) Market

Published:
Report ID: 50949

Multiplex Biomarker Imaging Market

Published:
Report ID: 43073

Multiple Sclerosis Treatment Market

Published:
Report ID: 20250

Related Reports

Artificial Intelligence Drug Development Market

Published:
Report ID: 89018

Seasonal Influenza Vaccines Therapeutics Market

Published:
Report ID: 88303

UK Offsite Medical Case Management Market

Published:
Report ID: 88149

Injection and Infusion Medical Consumable Market

Published:
Report ID: 87988

Australia Offsite Medical Case Management Market

Published:
Report ID: 87926

North American Offsite Medical Case Management Market

Published:
Report ID: 87897

Indonesia Disposable Medical Supplies Market

Published:
Report ID: 87389

Middle East Disposable Medical Supplies Market

Published:
Report ID: 87341

Asia Pacific Disposable Medical Supplies Market

Published:
Report ID: 87328

Brazil Offsite Medical Case Management Market

Published:
Report ID: 87232

Japan Offsite Medical Case Management Market

Published:
Report ID: 87239

Impurity Identification and Characterization Market

Published:
Report ID: 86809

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Let us help you

Credence Staff 3

MIKE, North America

+1 304 308 1216

Support Staff at Credence Research

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Smallform of Sample request

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN

Request Sample